Study of Mental Care in Spain
Information source: AstraZeneca
Information obtained from ClinicalTrials.gov on February 12, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Schizophrenia
Phase: N/A
Status: Not yet recruiting
Sponsored by: AstraZeneca Official(s) and/or principal investigator(s):
Manuel Gomez-Beneyto, Study Chair, Affiliation: University of Valencia
Alberto Gonzalez, Study Chair, Affiliation: Hospital Universitario Principe de Asturias
Overall contact:
AstraZeneca Spain Clinical Study Information, Phone: +34 913019243, Email: esteban.medina@astrazeneca.com
Summary
Non-interventional, multicenter, cross-sectional study to evaluate the mental care received
by schizophrenic patients and their caregivers in Spain irrespective of the drug prescribed.
Clinical Details
Official title: Study of Mental Care in Spain
Study design: Other, Cross-Sectional
Primary outcome: Camberwell's scale of Needs Analysis (CAN)Caregiver Needs Questionnaire(CNF)
Secondary outcome: Health of the Nation Outcome Scales (HoNOS)
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Schizophrenia (DSM-IV criteria)
- Attended to the mental care units for the first time in 2006
Exclusion Criteria:
- Participation in another clinical trial
- Other criteria that according to the medical criteria make difficult the normal
development of the study
Locations and Contacts
AstraZeneca Spain Clinical Study Information, Phone: +34 913019243, Email: esteban.medina@astrazeneca.com
Research Site, Cordoba, Spain
Research Site, Girona, Spain
Research Site, Madrid, Spain
Research Site, Ferrol, A Coruna, Spain
Research Site, Aviles, Asturias, Spain
Research Site, Jerez de la Frontera, Cadiz, Spain
Research Site, Torrejon de Ardoz, Castellon, Spain
Research Site, La Plana, Valencia, Spain
Research Site, Bilbao, Vizcaya, Spain
Additional Information
Starting date: January 2009
Ending date: August 2009
Last updated: January 15, 2009
|
